Cancer Treatment-Related Radiodermatitis
Publication Date: October 31, 2020
Last Updated: December 19, 2022
Recommendations
Among individuals receiving radiation therapy to the truncal/chest region, the ONS Guidelines panel suggests either deodorant/antiperspirant use plus standard washing/skincare regimen or standard washing/skincare regimen alone.
( Conditional , Very low)Remarks: This decision will be driven by the values and preferences of the patient. Education should include that antiperspirants/deodorant do not seem to cause harm, sweating is decreased, and the risk of grade 2 or 3 radiodermatitis is not increased.
7037
Title
Cancer Treatment-Related Radiodermatitis